En esta página
TCRX TScan Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$0,32
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,29mínimo 52 semanas
$2,57máximo 52 semanas
Capitalización Bursátil (MRQ)
$20M
P/E (TTM)
-0.4
BPA (TTM)
$-0.91
Ingresos (TTM)
$7M
tus insignias
Rango 52S
$0–$3
Calificación del Analista
BUY
Precio Objetivo
$1
P/E
-0.4
ROE
-95.8%
Margen de Beneficio Neto
-1655.4%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
TCRX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.32
Capitalización Bursátil (MRQ)
$20M
P/E (TTM)
-0.4
BPA (TTM)
$-0.91
Ingresos (TTM)
$7M
ROE (TTM)
-95.8%
Deuda/Capital (MRQ)
0.5
Rango 52S
$0–$3
TCRX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$10M2020-12-31 → 2025-12-31
BPA$-1.002021-12-31 → 2025-12-31
Flujo de caja libre$-140M2021-12-31 → 2025-12-31
Margen neto-1655.4%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TCRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -0.4promedio 5A ≈-1.9 | ≈-1.9 | · | · | |
| P/S (TTM) | 2.9 | · | 26.7 | Infravalorado | |
| P/C (MRQ) | 0.3 | · | 1.5 | Infravalorado | |
| Precio / FCF (TTM) | -0.2 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -0.2 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TCRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -1695.1%promedio 5A ≈-1768.8% | ≈-1768.8% | · | · | |
| EBITDA Margin (Margen EBITDA) | -1315.4%promedio 5A ≈-1768.8% | ≈-1768.8% | · | · | |
| Margen de Beneficio Neto (TTM) | -1655.4%promedio 5A ≈-1688.3% | ≈-1688.3% | · | · | |
| ROA (TTM) | -50.1%promedio 5A ≈-39.5% | ≈-39.5% | -56.1% | De primer nivel | |
| ROE (TTM) | -95.8%promedio 5A ≈-57.8% | ≈-57.8% | -86.6% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TCRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.5promedio 5A ≈0.2 | ≈0.2 | · | · | |
| Ratio corriente (MRQ) | 3.4promedio 5A ≈7.9 | ≈7.9 | 2.3 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 8.2promedio 5A ≈7.7 | ≈7.7 | 2.0 | Liquidez sólida | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.3promedio 5A ≈0.2 | ≈0.2 | · | · | |
| Interest Coverage (Cobertura de Intereses) | -49.0promedio 5A ≈-47.5 | ≈-47.5 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | TCRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 266.7%promedio 5A ≈220.7% | ≈220.7% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -8.6%promedio 5A ≈41.8% | ≈41.8% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 56.9% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | TCRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$74.8K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
2.7%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 19, 2026 | $-0.23 | $-0.22 | -5.0% |
| 31 de marzo de 2026 | May 12, 2026 | $-0.22 | $-0.18 | -25.4% |
| 31 de diciembre de 2025 | $-0.18 | $-0.25 | 26.8% | |
| 30 de septiembre de 2025 | $-0.28 | $-0.30 | 7.0% | |
| 30 de junio de 2025 | $-0.28 | $-0.29 | 2.2% | |
| 31 de marzo de 2025 | $-0.26 | $-0.29 | 10.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | $3M | $21M | $14M | $10M | $1M | |
| R&D Expense | $114M | $107M | $88M | $60M | $45M | $21M | |
| SG&A Expense | $32M | $30M | $26M | $20M | $14M | $7M | |
| Operating Expenses | $146M | $138M | $115M | $80M | $59M | $27M | |
| Operating Income | $-136M | $-135M | $-93M | $-67M | $-49M | $-26M | |
| Interest Expense | $3M | $4M | $4M | $1M | · | · | |
| Other Non-op | $6M | $7M | $4M | $415.0K | $16.0K | · | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-130M | $-127M | $-89M | $-66M | $-49M | $-26M | |
| EPS (Basic) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | · | |
| EPS (Diluted) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | · | |
| Shares (Basic) | 129,777,415 | 111,990,417 | 65,599,858 | 24,048,267 | 11,662,672 | · | |
| Shares (Diluted) | 129,777,415 | 111,990,417 | 65,599,858 | 24,048,267 | 11,662,672 | · | |
| EBITDA | $-136M | $-135M | · | $-67M | $-49M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $152M | $179M | $133M | $120M | $161M | $35M | |
| Short-term Investments | · | $111M | $59M | · | · | · | |
| Prepaid Expense | $5M | $3M | $2M | $4M | $4M | $2M | |
| Current Assets | $157M | $293M | $194M | $124M | $166M | $36M | |
| PP&E (Net) | $9M | $7M | $8M | $10M | $12M | $6M | |
| PP&E (Gross) | $30M | $26M | $22M | $20M | $17M | $7M | |
| Accum. Depreciation | $22M | $19M | $15M | $10M | $5M | $2M | |
| Total Assets | $229M | $371M | $272M | $199M | $188M | $50M | |
| Accounts Payable | $1M | $4M | $2M | $3M | $2M | $3M | |
| Current Liabilities | $19M | $36M | $30M | $17M | $21M | $17M | |
| Capital Leases | $54M | $61M | $59M | $53M | $4M | $6M | |
| Other Non-current Liabilities | · | $135.0K | · | $49.0K | $97.0K | $238.0K | |
| Total Liabilities | $106M | $130M | $121M | $100M | $27M | $33M | |
| Long-term Debt | $33M | $32M | $30M | $29M | · | · | |
| Total Debt | $33M | $32M | · | $29M | · | · | |
| Common Stock | · | · | · | · | · | $1.0K | |
| Retained Earnings | $-505M | $-375M | $-248M | $-158M | $-92M | $-44M | |
| AOCI | · | $51.0K | · | · | · | · | |
| Stockholders' Equity | $123M | $241M | $151M | $99M | $161M | $-42M | |
| Liabilities + Equity | $229M | $371M | $272M | $199M | $188M | $50M | |
| Shares Outstanding | 52,625,035 | 52,314,039 | · | 19,082,820 | 18,764,463 | 1,135,858 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $5M | $5M | $3M | $1M | |
| Stock-based Comp | $12M | $10M | $5M | $5M | $3M | $515.0K | |
| Operating Cash Flow | $-135M | $-111M | $-61M | $-67M | $-49M | $-3M | |
| CapEx | $4M | $4M | $3M | $4M | $10M | $4M | |
| Investing Cash Flow | $109M | $-53M | $-61M | $-4M | $-10M | $-4M | |
| Debt Issued | · | · | · | $29M | · | · | |
| Net Debt Issued | · | · | · | $29M | · | · | |
| Stock Issued | · | $33M | $42M | $193.0K | · | · | |
| Net Stock Activity | · | $33M | · | $193.0K | · | · | |
| Financing Cash Flow | $-336.0K | $209M | $135M | $29M | $190M | $288.0K | |
| Net Change in Cash | $-26M | $45M | $13M | $-41M | $131M | $-7M | |
| Free Cash Flow | $-140M | $-115M | · | $-71M | $-59M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1315.4% | -4787.7% | · | -492.3% | -479.6% | · | |
| Net Margin | -1256.8% | -4527.7% | · | -489.3% | -479.5% | · | |
| EBITDA Margin | -1315.4% | -4787.7% | · | -492.3% | -479.6% | · | |
| ROA | -43.3% | -39.6% | · | -34.2% | -40.9% | · | |
| ROE | -86.6% | -54.2% | · | -61.3% | -29.0% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 8.1 | · | 7.2 | 7.8 | · | |
| Quick Ratio | 8.2 | 8.1 | · | 6.9 | 7.6 | · | |
| Debt / Equity | 0.3 | 0.1 | · | 0.3 | · | · | |
| LT Debt / Equity | 0.3 | 0.1 | · | 0.3 | · | · | |
| Interest Coverage | -49.0 | -36.9 | · | -56.7 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.08 | $0.03 | · | $0.56 | · | · | |
| Cash Flow / Share | $-1.04 | $-0.99 | · | $-2.77 | · | · | |
| EPS (TTM) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 266.7% | -86.6% | 55.5% | 33.5% | 834.7% | · | |
| Revenue CAGR 3Y | -8.6% | -34.8% | 168.7% | · | · | · | |
| Revenue CAGR 5Y | 56.9% | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $3M | $21M | $14M | $10M | · | |
| Net Income TTM | $-130M | $-127M | $-89M | $-66M | $-49M | · | |
| P/E | -1.0 | -2.7 | -4.3 | -0.6 | -1.1 | · | |
| Earnings Yield | -100.0% | -37.5% | -23.3% | -177.4% | -92.7% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $982.0K | $3M | $3M | $3M | $2M | $665.0K | $1M | $536.0K | $566.0K | $7M | $4M | $3M | $7M | $3M | $3M | |
| R&D Expense | $23M | $22M | $20M | $32M | $33M | $30M | $29M | $26M | $27M | $25M | $22M | $23M | $21M | $22M | $16M | $15M | |
| SG&A Expense | $8M | $8M | $6M | $8M | $9M | $9M | $8M | $7M | $8M | $7M | $6M | $6M | $7M | $8M | $6M | $5M | |
| Operating Expenses | $32M | $30M | $26M | $40M | $42M | $38M | $37M | $34M | $35M | $32M | $29M | $29M | $28M | $30M | $22M | $20M | |
| Operating Income | $-30M | $-29M | $-24M | $-37M | $-39M | $-36M | $-37M | $-33M | $-34M | $-31M | $-21M | $-25M | $-25M | $-23M | $-19M | $-17M | |
| Interest Expense | $699.0K | $689.0K | $702.0K | $699.0K | $689.0K | $679.0K | $784.0K | $958.0K | $952.0K | $959.0K | $852.0K | $982.0K | $969.0K | $956.0K | $975.0K | $201.0K | |
| Other Non-op | $134.0K | $473.0K | $881.0K | $1M | $2M | $2M | $903.0K | $3M | $2M | $1M | $2M | $2M | $565.0K | $180.0K | $-74.0K | $333.0K | |
| Net Income | $-30M | $-29M | $-23M | $-36M | $-37M | $-34M | $-36M | $-30M | $-32M | $-30M | $-20M | $-23M | $-24M | $-23M | $-19M | $-16M | |
| EPS (Basic) | $-0.23 | $-0.22 | $-0.18 | $-0.28 | $-0.28 | $-0.26 | $-0.29 | $-0.25 | $-0.28 | $-0.32 | $0.32 | $-0.24 | $-0.51 | $-0.93 | $-0.78 | $-0.67 | |
| EPS (Diluted) | $-0.23 | $-0.22 | $-0.18 | $-0.28 | $-0.28 | $-0.26 | $-0.29 | $-0.25 | $-0.28 | $-0.32 | $0.32 | $-0.24 | $-0.51 | $-0.93 | $-0.78 | $-0.67 | |
| Shares (Basic) | 129,948,878 | 129,913,376 | · | 129,835,938 | 129,730,451 | 129,678,572 | · | 118,700,362 | 113,425,357 | 94,875,893 | · | 94,829,844 | 47,208,664 | 24,225,954 | · | 24,073,935 | |
| Shares (Diluted) | 129,948,878 | 129,913,376 | · | 129,835,938 | 129,730,451 | 129,678,572 | · | 118,700,362 | 113,425,357 | 94,875,893 | · | 94,829,844 | 47,208,664 | 24,225,954 | · | 24,073,935 | |
| EBITDA | $-30M | $-29M | · | $-37M | $-39M | $-36M | · | $-33M | $-34M | $-31M | · | $-25M | $-25M | $-23M | · | $-17M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $128M | $152M | $170M | $169M | $154M | $179M | $133M | $242M | $141M | $133M | $155M | $209M | $96M | $120M | $137M | |
| Short-term Investments | · | · | · | $15M | $49M | $98M | $111M | $138M | $56M | $22M | $59M | $60M | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | $32M | · | · | · | |
| Prepaid Expense | $4M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $5M | $4M | $4M | |
| Current Assets | $104M | $133M | $157M | $188M | $221M | $255M | $293M | $274M | $300M | $165M | $194M | $218M | $242M | $101M | $124M | $141M | |
| PP&E (Net) | $8M | $8M | $9M | $9M | $10M | $8M | $7M | $7M | $8M | $7M | $8M | $9M | $8M | $9M | $10M | $10M | |
| PP&E (Gross) | · | · | $30M | · | · | · | $26M | · | · | · | $22M | · | · | · | $20M | · | |
| Accum. Depreciation | · | · | $22M | · | · | · | $19M | · | · | · | $15M | · | · | · | $10M | · | |
| Total Assets | $171M | $202M | $229M | $262M | $299M | $333M | $371M | $348M | $375M | $241M | $272M | $291M | $317M | $174M | $199M | $165M | |
| Accounts Payable | $3M | $2M | $1M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Current Liabilities | $31M | $20M | $19M | $29M | $31M | $30M | $36M | $29M | $39M | $31M | $30M | $33M | $35M | $14M | $17M | $17M | |
| Capital Leases | $50M | $52M | $54M | $56M | $58M | $60M | $61M | $56M | $57M | $58M | $59M | $53M | $54M | $52M | $53M | $3M | |
| Other Non-current Liabilities | · | · | · | $278.0K | $113.0K | $124.0K | $135.0K | $146.0K | · | · | · | $12.0K | $24.0K | $36.0K | $49.0K | $97.0K | |
| Total Liabilities | $102M | $105M | $106M | $118M | $122M | $123M | $130M | $119M | $120M | $118M | $121M | $122M | $126M | $96M | $100M | $49M | |
| Long-term Debt | $33M | $33M | $33M | $32M | $32M | $32M | · | $31M | $30M | $30M | $30M | $30M | $30M | $30M | · | $29M | |
| Total Debt | $33M | $33M | · | $32M | $32M | $32M | · | $31M | $30M | $30M | · | $30M | $30M | $30M | · | $29M | |
| Retained Earnings | $-564M | $-534M | $-505M | $-482M | $-446M | $-409M | $-375M | $-339M | $-309M | $-278M | $-248M | $-228M | $-205M | $-181M | $-158M | $-140M | |
| AOCI | · | · | · | $2.0K | $-4.0K | $-4.0K | $51.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $69M | $97M | $123M | $144M | $177M | $210M | $241M | $229M | $255M | $123M | $151M | $169M | $191M | $78M | $99M | $117M | |
| Liabilities + Equity | $171M | $202M | $229M | $262M | $299M | $333M | $371M | $348M | $375M | $241M | $272M | $291M | $317M | $174M | $199M | $165M | |
| Shares Outstanding | 63,502,667 | 55,824,722 | · | · | · | · | · | · | · | · | · | 43,546,528 | 43,542,178 | 19,480,729 | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-28M | $-24M | $-32M | $-32M | $-33M | $-38M | $-27M | $-28M | $-26M | $-29M | $-24M | $8M | $-22M | $-24M | $-16M | $-17M | |
| CapEx | $493.0K | $70.0K | $171.0K | $1M | $1M | $2M | $888.0K | $1M | $862.0K | $705.0K | $469.0K | $1M | $420.0K | $838.0K | $1M | $424.0K | |
| Investing Cash Flow | $-465.0K | $-70.0K | $15M | $33M | $48M | $14M | $27M | $-82M | $-34M | $36M | $2M | $-61M | $-420.0K | $-838.0K | $-1M | $-424.0K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $-186.0K | · | · | · | · | |
| Financing Cash Flow | · | · | $73.0K | $0 | $116.0K | $-525.0K | $46M | $1M | $162M | $258.0K | $19.0K | $-252.0K | · | · | $108.0K | $29M | |
| Net Change in Cash | $-28M | $-24M | $-17M | $112.0K | $15M | $-25M | $46M | $-109M | $102M | $7M | $-22M | $-54M | $113M | $-24M | $-17M | $12M | |
| Free Cash Flow | · | $-24M | · | · | · | $-39M | · | · | · | $-30M | · | · | · | $-24M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2901.3% | -2967.3% | · | -1475.6% | -1256.6% | -1669.7% | · | -3109.8% | -6364.6% | -5542.9% | · | -636.7% | -781.8% | -334.3% | · | -492.9% | |
| Net Margin | -2888.6% | -2919.1% | · | -1422.1% | -1201.3% | -1572.0% | · | -2849.1% | -5906.9% | -5325.4% | · | -591.6% | -763.8% | -331.7% | · | -483.0% | |
| EBITDA Margin | -2901.3% | -2967.3% | · | -1475.6% | -1256.6% | -1669.7% | · | -3109.8% | -6364.6% | -5542.9% | · | -636.7% | -781.8% | -334.3% | · | -492.9% | |
| ROA | -12.9% | -10.7% | · | -11.7% | -11.0% | -11.9% | · | -9.3% | -9.2% | -14.5% | · | -10.1% | -10.2% | -13.2% | · | -8.8% | |
| ROE | -24.7% | -18.7% | · | -19.1% | -17.1% | -20.5% | · | -15.0% | -14.2% | -30.0% | · | -16.1% | -14.9% | -20.2% | · | -11.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 6.6 | · | 6.4 | 7.1 | 8.5 | · | 9.6 | 7.8 | 5.2 | · | 6.6 | 6.9 | 7.2 | · | 8.5 | |
| Quick Ratio | 3.2 | 6.4 | · | 6.3 | 7.0 | 8.4 | · | 9.5 | 7.7 | 5.2 | · | 6.5 | 6.9 | 6.8 | · | 8.3 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.2 | |
| LT Debt / Equity | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.2 | |
| Interest Coverage | -43.6 | -42.3 | · | -53.0 | -56.1 | -53.4 | · | -34.1 | -35.8 | -32.7 | · | -25.2 | -25.4 | -23.8 | · | -82.5 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 0.2 | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.09 | $1.74 | · | · | · | · | · | · | · | · | · | $3.88 | $4.38 | $4.00 | · | · | |
| Revenue / Share | $0.01 | $0.01 | · | $0.02 | $0.02 | $0.02 | · | $0.01 | $0.00 | $0.01 | · | $0.04 | $0.07 | $0.28 | · | $0.14 | |
| Cash Flow / Share | · | $-0.19 | · | · | · | $-0.29 | · | · | · | $-0.31 | · | · | · | $-0.97 | · | · | |
| Cash / Share | $1.58 | $2.29 | · | · | · | · | · | · | · | · | · | $3.56 | $4.80 | $4.91 | · | · | |
| EPS (TTM) | $-0.91 | $-0.96 | · | $-1.11 | $-1.08 | $-1.08 | · | $-0.53 | $-0.52 | $-0.75 | · | $-2.46 | $-2.89 | $-3.01 | · | $-1.59 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $9M | · | $8M | $7M | $4M | · | $9M | $12M | $15M | · | $17M | $16M | $17M | · | $13M | |
| Net Income TTM | $-118M | $-124M | · | $-143M | $-137M | $-131M | · | $-111M | $-104M | $-97M | · | $-88M | $-82M | $-73M | · | $-62M | |
| Market Cap | $62M | $56M | · | · | · | · | · | · | · | · | · | $111M | $109M | $41M | · | · | |
| Enterprise Value | $-5M | $-39M | · | · | · | · | · | · | · | · | · | $-74M | $-70M | $-25M | · | · | |
| P/E | -1.1 | -1.1 | · | -1.6 | -1.3 | -1.3 | · | -9.4 | -11.2 | -10.6 | · | -1.0 | -0.9 | -0.7 | · | -1.9 | |
| P/S | 8.8 | 6.2 | · | · | · | · | · | · | · | · | · | 6.6 | 6.6 | 2.4 | · | · | |
| P/B | 0.9 | 0.6 | · | · | · | · | · | · | · | · | · | 0.7 | 0.6 | 0.5 | · | · | |
| P / Tangible Book | 0.9 | 0.6 | · | · | · | · | · | · | · | · | · | 0.7 | 0.6 | 0.5 | · | · | |
| P / Cash Flow | · | -2.3 | · | · | · | · | · | · | · | · | · | · | · | -1.7 | · | · | |
| EV / Revenue | -0.7 | -4.3 | · | · | · | · | · | · | · | · | · | -4.4 | -4.3 | -1.5 | · | · | |
| Earnings Yield | -92.9% | -95.0% | · | -61.0% | -74.5% | -78.3% | · | -10.6% | -8.9% | -9.4% | · | -96.1% | -115.6% | -143.3% | · | -52.1% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $10M | $3M | $21M | $14M | $10M |
| Margen Operativo % | -1315.4% | -4787.7% | · | -492.3% | -479.6% |
| Beneficio neto | $-130M | $-127M | $-89M | $-66M | $-49M |
| EPS Diluido | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.3 | 0.1 | · | 0.3 | · |
| Ratio corriente | 8.4 | 8.1 | · | 7.2 | 7.8 |
| Ratio Rápido | 8.2 | 8.1 | · | 6.9 | 7.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-140M | $-115M | · | $-71M | $-59M |
Propietarios institucionales (13F) 64 declarantes · $36.1M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
64
Valor en tenencia
$36.1M
Nuevas posiciones
8
Posiciones cerradas
7
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 8 (-2 vs trimestre anterior) | 7 (-3 vs trimestre anterior) | 22 (+7 vs trimestre anterior) | 12 (-8 vs trimestre anterior) | +3.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $7 859 567 | 8 019 148 | 21,78% | Acciones |
| BVF INC/IL | $5 453 561 | 5 564 290 | 15,12% | Acciones |
| BAKER BROS. ADVISORS LP | $2 729 375 | 2 784 792 | 7,56% | Acciones |
| VANGUARD GROUP INC | $2 475 733 | 2 475 733 | 6,86% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $2 115 654 | 2 158 831 | 5,86% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 910 807 | 1 949 604 | 5,30% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 300 396 | 1 326 799 | 3,60% | Acciones |
| Deer Management Co. LLC | $1 220 594 | 1 245 504 | 3,38% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $1 140 455 | 1 163 611 | 3,16% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1 028 915 | 1 049 806 | 2,85% | Acciones |
| CITADEL ADVISORS LLC | $989 026 | 1 009 107 | 2,74% | Acciones |
| BlackRock, Inc. | $974 860 | 994 654 | 2,70% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $756 873 | 772 241 | 2,10% | Acciones |
| MARSHALL WACE, LLP | $673 616 | 687 364 | 1,87% | Acciones |
| DC Funds, LP | $617 463 | 630 000 | 1,71% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $573 401 | 584 811 | 1,59% | Acciones |
| D. E. Shaw & Co., Inc. | $537 489 | 548 402 | 1,49% | Acciones |
| Kalehua Capital Management LLC | $445 824 | 454 876 | 1,24% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $356 675 | 363 954 | 0,99% | Acciones |
| TWO SIGMA ADVISERS, LP | $353 900 | 353 900 | 0,98% | Acciones |
| JANE STREET GROUP, LLC | $236 687 | 241 493 | 0,66% | Acciones |
| Verdad Advisers, LP | $228 127 | 232 759 | 0,63% | Acciones |
| STATE STREET CORP | $203 187 | 207 313 | 0,56% | Acciones |
| MIZUHO SECURITIES USA LLC | $201 509 | 205 600 | 0,56% | Acciones |
| MORGAN STANLEY | $193 952 | 197 891 | 0,54% | Acciones |
| XTX Topco Ltd | $146 493 | 149 467 | 0,41% | Acciones |
| BROWN BROTHERS HARRIMAN & CO | $140 204 | 143 051 | 0,39% | Acciones |
| NORTHERN TRUST CORP | $136 016 | 138 778 | 0,38% | Acciones |
| LETKO, BROSSEAU & ASSOCIATES INC | $93 967 | 95 875 | 0,26% | Acciones |
| NewEdge Wealth, LLC | $89 643 | 91 463 | 0,25% | Acciones |
| Cubist Systematic Strategies, LLC | $76 582 | 42 078 | 0,21% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $75 370 | 76 900 | 0,21% | Acciones |
| GOLDMAN SACHS GROUP INC | $69 111 | 70 514 | 0,19% | Acciones |
| AMERIPRISE FINANCIAL INC | $68 104 | 69 487 | 0,19% | Acciones |
| UBS Group AG | $67 495 | 68 873 | 0,19% | Acciones |
| STIFEL FINANCIAL CORP | $66 838 | 68 200 | 0,19% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $64 028 | 65 335 | 0,18% | Acciones |
| Kestra Advisory Services, LLC | $61 281 | 62 525 | 0,17% | Acciones |
| BANK OF AMERICA CORP /DE/ | $48 118 | 49 100 | 0,13% | Acciones |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $35 872 | 36 600 | 0,10% | Acciones |
| DC Investments Management, LLC | $34 855 | 35 563 | 0,10% | Acciones |
| Point72 Asia (Singapore) Pte. Ltd. | $26 454 | 14 535 | 0,07% | Acciones |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $25 349 | 25 864 | 0,07% | Acciones |
| HSBC HOLDINGS PLC | $23 842 | 24 574 | 0,07% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $23 153 | 23 623 | 0,06% | Acciones |
| BARCLAYS PLC | $18 788 | 19 170 | 0,05% | Acciones |
| R Squared Ltd | $17 995 | 18 360 | 0,05% | Acciones |
| Vanguard Personalized Indexing Management, LLC | $17 602 | 17 959 | 0,05% | Acciones |
| JPMORGAN CHASE & CO | $16 089 | 16 458 | 0,04% | Acciones |
| Vanguard Global Advisers, LLC | $15 391 | 15 705 | 0,04% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×4 presentaciones | 23 de abril de 2024 | · | Presentación inicial | Estructura de capital | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 17 insiders · 9 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Gavin Macbeath | Chief Executive Officer | 1 de octubre de 2026 A | 1 049 767 | 0 | 0 | $0 |
| David P Southwell | Chief Executive Officer | 2 de febrero de 2023 A | 171 569 | 0 | 0 | $0 |
| Jason Amello | Chief Financial Officer | 20 de enero de 2026 A | · | 0 | 0 | $0 |
| Brian M. Silver | Chief Financial Officer | 13 de junio de 2023 A | 32 885 | 0 | 0 | $0 |
| Zoran Zdraveski | Chief Legal and Strategy Officer | 1 de octubre de 2026 A | 304 716 | 0 | 0 | $0 |
| Chrystal Louis | Chief Medical Officer | 20 de enero de 2026 A | · | 0 | 0 | $0 |
| Leiden Dworak | Principal Accounting Officer and Vice President, Finance | 20 de enero de 2026 A | · | 0 | 0 | $0 |
| Debora Barton | Chief Medical Officer | 13 de junio de 2023 A | · | 0 | 0 | $0 |
| William Desmarais | Chief Business Officer | 25 de julio de 2022 A | 2 500 | 0 | 0 | $0 |
| Keith Woods | Consejero | 20 de mayo de 2026 A | · | 0 | 0 | $0 |
| Gabriela Gruia | Consejero | 20 de mayo de 2026 A | · | 0 | 0 | $0 |
| Barbara Klencke | Consejero | 20 de mayo de 2026 A | 45 000 | 0 | 0 | $0 |
| Garry A Nicholson | Consejero | 20 de mayo de 2026 A | · | 0 | 0 | $0 |
| Katina Dorton | Consejero | 20 de mayo de 2026 A | · | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | Consejero | 19 de diciembre de 2023 P | 67 027 | 0 | 0 | $0 |
| Ittai Harel | Consejero | 1 de junio de 2022 A | · | 0 | 0 | $0 |
| Christoph H Westphal | Propietario del 10% | 20 de julio de 2021 C | 1 278 838 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
TCRX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 13 analistas
COMPRA
Objetivo mediano
$1.00
+212,0%
3 23,1%
Compra fuerte
7 53,8%
Compra
3 23,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
2 analistas · 2026-10-02Objetivo medio $1.00 +212,0%
Mín$1.00
Media$1.00
Máx$1.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026